POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml

7680682710027 CH-68271 J02AC04 08.06.0.

Reimbursement limitations:

NOXAFIL2

La prophylaxie chez des patients à risque élevé (voir 1a et 1b) peut être prescrit …

POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
1 / 3
google

Details

Product number
6827101
CPT
-
Packaging group
105
Unit
ml
Composition
posaconazolum 200 mg, acidum citricum monohydricum, natrii dihydrogenocitras anhydricus, natrii benzoas 10 mg, natrii laurilsulfas, simeticonum, methylcellulosum, acidum sorbicum, xanthani gummi, glycerolum, glucosum liquidum 2108.5 mg, E 171, aromatica (Kirschen), aqua purificata ad suspensionem pro 5 ml corresp. natrium 5.91 mg.

Articles (1)

Posaconazol Viatris 40 mg/ml, Suspension zum Einnehmen
suspension
105
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/07/2025
Patient information leaflet
Français
10/07/2025
Patient information leaflet
Italien
10/07/2025
Professional SmPC
Allemand
10/07/2025
Professional SmPC
Français
10/07/2025
Professional SmPC
Italien
10/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.0 MG Substance HBESI
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2108.5 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HNIDK
(N/A)
5.91 MG Substance HBESI

Reimbursement information

Public price
CHF 574.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/10/2021

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
68271
Drug name
Posaconazol Viatris, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
J02AC04
Authorization status
Z
Dispensation category
B
First authorization
19/07/2021
Authorization expiration date
18/07/2026
IT number
08.06.0.
Domain
Human medicine
Field of application
Pilzinfektionen

Packaging details

Description (FR)
POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
Description (DE)
POSACONAZOL Viatris Susp 40 mg/ml z Einnehm 105 ml
Market launch
19/07/2021
Narcotic (BTM)
No

Original drug

Noxafil, Konzentrat zur Herstellung einer Infusionslösung
CHF 456.15
View original

Other packaging sizes